Impact of crystalloid HTK and St. Thomas' cardioplegia on myocardial fluid balance and postcardioplegic stunning

Cardiovascular Engineering

Volumn 8, Issue 1-2, 2003, Pages 58-65

  Sauer, H Henning ^a,c   Allen, S J ^a   Laine, G A ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c KLINIKUM OLDENBURG   (Germany)

Author keywords

Cardioplegia; Mannitol; Myocardial edema; PMNs; PRSW

Indexed keywords

CARDIOPLEGIC AGENT; HTK SOLUTION; MANNITOL; MYELOPEROXIDASE; PLEGISOL; ST THOMAS HOSPITAL SOLUTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CELL INFILTRATION; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; FLUID BALANCE; GRAVIMETRY; HEART ARREST; HEART DISEASE; HEART EDEMA; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE REPERFUSION; HEART STROKE VOLUME; HEMODYNAMICS; HYPEROSMOLALITY; INDUCED HYPOTENSION; NEUTROPHIL; NONHUMAN; PRELOAD RECRUITABLE STROKE WORK; PRIORITY JOURNAL; SONOMICROMETER; STUNNED HEART MUSCLE; WATER CONTENT;

EID: 0041317807     PISSN: 14329077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Mehlhorn U, Davis KL, Burke EJ, Adams DL, Laine GA, Allen SJ (1995) Impact of cardiopulmonary bypass and cardioplegic arrest on myocardial lymphatic function. Am J Physiol 268: H178-H183
2. Krukenkamp IB, Levitsky S (1996) Physiological and cellular mechanisms of myocardial protection. Am J Surg 172: 79-84
3. Hendry PJ, Masters RG, Haspect A (1994) Is there a place for cold crystalloid cardioplegia in the 1990s? Ann Thorac Surg 58: 1690-1694
4. Laine GA, Granger HJ (1985) Microvascular, interstitial, and lymphatic interactions in normal heart. Am J Physiol 249: H834-H842
5. Shaffer RF, Baumgarten CM, Damiano RJ Jr. (1998) Prevention of cellular edema directly caused by hypothermic cardioplegia: studies in isolated human and rabbit atrial myocytes. J Thorac Cardiovasc Surg 115: 1189-1195
6. Sellke FW (1997) Microvascular dysfunction following global ischemia and reperfusion. In: Haunso S, Aldershvile J, Svendsen JH (Eds.) Coronary microcirculation during ischemia and reperfusion (pp. 422-432). Copenhagen: Munksgaard
7. Magovern GJ, Bolling SF, Casale AS, Bulkley BH, Gardner TJ (1984) The mechanism of mannitol in reducing ischemic injury; hyperosmolarity or hydroxyl scavenger? Circulation 70: 191-195
8. Mehlhorn U, Allen SJ, Adams DL et al. (1995) Normothermic continuous antegrade blood cardioplegia does not prevent myocardial edema and cardiac dysfunction. Circulation 92: 1939-1946
9. Mullane KM, Kraemer R, Smith B (1985) Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14: 157-167
10. Gebhard MM, Bretschneider HJ, Gersing E, Preusse CJ, Schnabel PhA, Ulbricht LJ (1983) Calcium-free cardioplegia - pro. Eur Heart J 4: 151-160
11. Stinner B, Krohn E, Gebhard MM, Bretschneider HJ (1989) Intracellular sodium activity and Bretschneider's cardioplegia: continuous measurement by ionselective microelectrodes at initial equilibration. Basic Res Cardiol 84: 197-207
12. Allen SJ, Drake RE (1997) Microvascular fluid exchange. In: Yaksh TL (Ed.) Anesthesia: biological foundations (pp. 1417-1430). Philadelphia: Lippincott-Raven Publ.
13. Weber K (1989) Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol 13: 1637-1652
14. Sun SC, Lie JT (1977) Cardiac lymphatic obstruction. Ultrastructure of acute-phase myocardial injury in dogs. Mayo Clin Proc 52: 785-792
15. Liposti JA, Alanen KA, Nevalainen TJ (1982) Effect of hypertonic mannitol and microvascular function in hypoxic and reoxygenated rat myocardium. Cardiovasc Res 16: 283-287
16. Carlson RE, Aisen AM, Buda AJ (1992) Effect of reduction in myocardial edema on myocardial blood flow and ventricular function after coronary reperfusion. Am J Physiol 262: H641-H648
17. Forman MB, Puett DW, Virmani R (1989) Endothelial and myocardial injury during ischemia and reperfusion: pathogenesis and therapeutic implications. J Am Coll Cardiol 13: 450-459
18. Human PA, Holl J, Vosloo S et al. (1993) Extended cardiopulmonary preservation: University of Wisconsin solution versus Bretschneider's cardioplegic solution. Ann Thorac Surg 55: 1123-1130
19. Garcia-Dorado D, Theroux P, Munoz R et al. (1992) Favorable effects of hyperosmotic reperfusion on myocardial edema and infarct size. Am J Physiol 262: H17-H22
20. Powers ER, DiBona DR, Powell WJ Jr. (1984) Myocardial cell volume and coronary resistance during diminished coronary perfusion. Am J Physiol 247: H467-H477
21. Sellke FW, Shafique T, Ely DL, Weintraub RM (1993) Coronary endothelial injury after cardiopulmonary bypass and ischemic cardioplegia is mediated by oxygen-derived free radicals. Circulation 88: 11395-11400
22. Bolli R (1992) Postischemic myocardial stunning: pathogenesis, pathophysiology, and clinical relevance. In: Yellon DM, Jennings RB (Eds.) Myocardial protection: the pathophysiology of reperfusion and reperfusion injury (pp. 105-149). New York: Raven Press
23. von Oppell UO, Pfeiffer S, Preiss P, Dunne T, Zilla P, Reichart B (1990) Endothelial cell toxicity of solid-organ preservation solutions. Ann Thorac Surg 50: 902-910
24. Mankad PS, Chester AH, Yacoub MH (1991) Role of potassium concentration in cardioplegic solutions in mediating endothelial damage. Ann Thorac Surg 51: 89-93
25. Carpentier S, Murawsky M, Carpentier A (1981) Cytotoxicity of cardioplegic solutions: evaluation by tissue culture. Circulation 64: 1190-1195
26. Bassenge E, Busse R (1988) Endothelial modulation of coronary tone. Prog Cardiovasc Dis 30: 349-380